Stefania Bettelli

Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis

Maria Vittoria Dieci, Elena Barbieri, Federico Piacentini et al. · Annals of Oncology · 2012 · 189 citations · Full text

Breast Oncology, Tumor Heterogeneity, Receptor Status +11

Comparison of HER-2 and Hormone Receptor Expression in Primary Breast Cancers and Asynchronous Paired Metastases: Impact on Patient Management

Valentina Guarneri, Simona Giovannelli, Guido Ficarra et al. · The Oncologist · 2008 · 152 citations · Full text

Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients

Valentina Guarneri, Maria Vittoria Dieci, Elena Barbieri et al. · Annals of Oncology · 2013 · 140 citations · Full text

Breast Oncology, Neoadjuvant Therapy, Medicine +8

Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer

Valentina Guarneri, Maria Vittoria Dieci, Antonio Frassoldati et al. · The Oncologist · 2015 · 109 citations · Full text

Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer

Carmelo Bengala, Stefania Bettelli, Federica Bertolini et al. · Annals of Oncology · 2008 · 89 citations · Full text

Radiation Therapy, Medicine, Pathology +5